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Abstract
Background: Feline infectious agent studies are lacking in Cyprus. The aims of this study were to determine the
prevalence and risk factors for various feline infectious agents, including feline vector-borne pathogens (FVBP), in
cats from Cyprus.
Methods: A cross-sectional, descriptive, multicentre study was performed on 174 feline samples [138 owned and
36 shelter-feral, including both healthy (43) and non-healthy (131), cats] from private veterinary clinics from all six
districts of Cyprus. Real-time quantitative polymerase chain reaction (qPCR) assays were used to detect Mycoplasma
haemofelis (Mhf), “Candidatus Mycoplasma haemominutum” (CMhm) and “Candidatus Mycoplasma turicensis” (CMt).
The population was tested for four FVBP including Bartonella henselae and Leishmania spp. using qPCR, while conventional
PCR assays were used to detect Ehrlichia/Anaplasma spp. and Hepatozoon spp. Serological assays were performed to detect
Leishmania infantum antibodies, feline leukaemia virus (FeLV) antigen and feline immunodeficiency virus (FIV) antibodies.
Statistical analysis was performed to test associations and possible risk factors between variables and infectious agents.
Results: Ninety-six (55.2%) of the 174 cats were PCR-positive for at least one infectious agent. Forty-six cats (26.4%) were
haemoplasma positive, including 13 (7.5%) for Mhf, 36 (20.7%) for CMhm and 12 (6.9%) for CMt. Sixty-six cats (37.9%) were
positive for Hepatozoon spp., while 19 (10.9%) were positive for B. henselae, four (2.3%) for Leishmania spp. and one (0.6%)
for Ehrlichia/Anaplasma spp. Sequencing revealed the presence of Hepatozoon felis, L. infantum and Anaplasma platys. Of
the 164 cats that underwent retroviral serology, 10 (6.1%) were FeLV-positive and 31 (18.9%) were FIV-positive, while L.
infantum serology was positive in 7 (4.4%) of the 160 cats tested. Multivariable logistic regression revealed significant
associations for various infectious agents including L. infantum with each of Hepatozoon spp. and CMt infection.
Conclusions: A high prevalence of infectious agents was found in cats from Cyprus with Mhf, CMhm, CMt, L. infantum, B.
henselae, H. felis, A. platys, FeLV and FIV infections reported for the first time. The significant associations between different
pathogens provide a better understanding of similarities in the epidemiology of these pathogens and interactions
between them.
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felis, Haemoplasma, FeLV, FIV
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Background
The Republic of Cyprus is an island state located at the
crossroads between Europe, Asia and Africa, with the
first evidence of cat domestication reported 9,500 years
ago [1]. It is the third largest Mediterranean island with
a territory of 9,251 km2 of which almost half is domi-
nated by mountain ranges. The climate of Cyprus is
warmer than the temperate climate typical of some other
European Mediterranean countries. This, combined with
the geographical location and other factors, favours the
maintenance of many arthropod vectors including ticks,
fleas, phlebotomine sand flies and mosquitoes [2–6].
While many studies on feline haemoplasmas, feline
leukaemia virus (FeLV) and feline immunodeficiency
virus (FIV) have been performed worldwide, feline
vector-borne pathogens (FVBP) have only been studied
relatively recently, and are showing an expanding distri-
bution [7–16]. This illustrates the potential cats have for
maintaining and distributing vector-borne pathogens
(VBP), some of which are zoonotic.
Vector-borne pathogens have been identified in the
government-controlled southern part of Cyprus in vari-
ous host animal species; Leishmania infantum, Ehrlichia
canis, Anaplasma platys, Hepatozoon canis, Babesia
vogeli and Mycoplasma haemocanis have been reported
in dogs [6, 17], and several rickettsial agents have been
reported in goats, sheep, cattle, dogs, mouflon, foxes and
hares [2, 3]. Until now, no epidemiological studies have
been performed for any infectious agent in cats from
Cyprus nor in any small animal species from the non-
government-controlled northern part of the country.
The aims of this study were to investigate the presence
of several infectious agents, including some FVBP with
zoonotic concern, in cats from the whole of Cyprus and
to identify risk factors associated with them using multi-
variable logistic regression. Specifically, we investigated
feline haemoplasmas [Mycoplasma haemofelis (Mhf),
“Candidatus Mycoplasma haemominutum” (CMhm)
and “Candidatus Mycoplasma turicensis” (CMt)],
Bartonella henselae, Hepatozoon spp., Leishmania spp.
and Ehrlichia/Anaplasma spp. using DNA-based de-
tection techniques. Additionally, specific antibodies
for FIV and Leishmania infantum antigens were de-
termined and antigenaemia was assessed for FeLV.
Methods
Animals and samples
From March to September 2014, a total of 176 cats from
veterinary clinics in Cyprus were studied. Cats were
from urban and rural areas of all six districts of the is-
land; Paphos, Nicosia, Larnaca, Limassol, Famagusta and
Kyrenia. Surplus EDTA-blood (0.5–1.0 ml), and when
possible serum (0.5–1.0 ml), were collected from cats
following written consent from the cat owner or person
in charge of the animal shelter. The healthy cat samples
comprised pre-anaesthetic screens or samples collected
for check-ups (e.g. pre- or post-traveling) whilst the
samples from clinically ill animals were taken for diag-
nostic investigations.
Samples were stored at -20 °C until transported on dry
ice to the Diagnostic Laboratories, Langford Vets, Uni-
versity of Bristol, UK, for testing. Data on age, gender
(male or female), breed (non-pedigree or pedigree),
housing (access to outdoors or indoors only), lifestyle
(shelter-feral or owned), district of cat origin in Cyprus
(Paphos, Nicosia, Larnaca, Limassol, Famagusta or
Kyrenia), habitat (rural or urban), any previous travel
history abroad (never travelled abroad or travelled
abroad) and health status (non-healthy or healthy, deter-
mined by the veterinarian) were registered for each cat.
Whenever available, data on the cat’s vaccination status
(never vaccinated or vaccinated), use of ectoparasitic
prevention (never used or used) and presence of an-
aemia (haematocrit < 25%), based on in-house complete
blood count, were also recorded.
Polymerase chain reaction (PCR) tests
The DNA was extracted from 100 μl of EDTA blood
using a commercial kit (Macherey-Nagel nucleospin
blood kit, Düren, Germany) according to the manufac-
turer's instructions. During extraction nuclease-free
water was used as a negative extraction control. The
DNA was eluted with 100 μl of elution buffer provided
with the kit and stored at -20 °C prior to analysis.
In order to assess the presence of amplifiable DNA, the
absence of PCR inhibitors and correct assay setup, all
quantitative (q) PCRs were duplexed with an internal
amplification control. For the haemoplasma qPCRs, the
feline 28S rRNA gene was used and a threshold cycle (Ct)
cut-off value of < 30 was used to indicate adequate ampli-
fiable DNA. For the Leishmania spp. and B. henselae
qPCRs, the glyceraldehyde-3-phosphate dehydrogenase
gene was used and a Ct value of < 27 was used as a cut-off.
Any samples with Ct values greater than or equal to the
cut-off values were excluded from the study due to insuffi-
cient quantity/quality of DNA. Multiplex qPCR assays, as
previously described, were used to detect infection with
Mhf, CMhm, CMt [18], Leishmania spp. (screening assay)
[19] and B. henselae [20], and a conventional PCR, as pre-
viously described, was used to detect infection with
Ehrlichia/Anaplasma spp. [21]. Table 1 lists all the primer
sequences and products sizes for the PCR assays used. A
novel PCR assay was designed and validated (see below)
for the detection of Hepatozoon spp. For each assay, DNA
from known infected cats (or dogs for Ehrlichia/Ana-
plasma spp., Hepatozoon spp. and Leishmania spp.) and
nuclease-free water were used as positive and negative
controls, respectively.
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The DNA from six samples that yielded positive
results with the screening Leishmania spp. qPCR
assay were shipped to the Koret School of Veterinary
Medicine, Hebrew University, Rehovot, Israel for
confirmatory Leishmania spp. qPCR analysis, using a
previously described assay [22, 23].
Novel Hepatozoon spp. PCR assay
The PCR assay for Hepatozoon spp. was based on the
18S rRNA gene. All available sequences larger than
1,000 bp for Hepatozoon felis, H. canis and Hepatozoon
americanum were downloaded from GenBank (https://
www.ncbi.nlm.nih.gov/genbank/) and aligned using CLC
Sequence Viewer 6.7.1. The 100% consensus sequence
was used with Primer3 (http://bioinfo.ut.ee/primer3-
0.4.0/primer3) to design primers and MFold (http://una
fold.rna.albany.edu/?q=mfold) was used to predict likely
secondary structures within the amplicon. The primers,
Hep for (5'-AAA CGG CTA CCA CAT NTA AGG A-3')
and Hep rev (5'-AATACA AAT GCC CCC AAC TNT-3')
were chosen, amplifying a PCR product of 504 bp for H.
canis and H. felis and 522 bp for H. americanum. Primers
were synthesised by Metabion International (Steinkirchen,
Germany).
Amplification was performed in a PeqStar 2X thermo-
cycler (Peqlab, Erlangen Germany). A final volume of
25 μl, containing 12.5 μl of 2× GoTaq G2 Master Mix
(Promega, Madison, USA), 7 μl of nuclease-free water,
0.5 μl of forward and reverse primer mix at 10 μM each
and 5 μl of DNA template, was used. Thermocycler con-
ditions were set at 95 °C for 2 min, followed by 40 cycles
of 95 °C for 15 s and 60 °C for 45 s. The DNA of a dog
and a cat previously diagnosed with H. canis and H. felis,
respectively, based on positive Hepatozoon spp. PCR
[24] and 18S rRNA gene sequencing, were used as posi-
tive controls. Nuclease-free water was used as a negative
control. All amplicons were run on a 2% agarose gel
(Appleton Woods, Birmingham, UK), using 1X TAE buf-
fer (Thermo Fisher Scientific, Paisley, UK) and ethidium
bromide (Sigma-Aldrich, St. Louis, USA) at a final con-
centration of 50 ng/ml of gel, at 100 V for 40 min and
an image of the gel was captured under ultraviolet light.
Specificity was evaluated using samples known to con-
tain H. felis, H. canis, B. canis, Babesia rossi, E. canis,
Anaplasma phagocytophilum, L. infantum, Bartonella
clarridgeiae, Mhf, CMhm, CMt, M. haemocanis, “Candi-
datus M. haematoparvum”, Neospora caninum and
Toxoplasma gondii DNA. Any amplicon produced
Table 1 Polymerase chain reaction details for the qPCR/PCR assays used in the study for the testing of infectious agents
Target species (target gene) PCR primer or probe sequences (5'–3') Product size (bp) Reference
Bartonella henselae (alr-gcvP intergenic spacer) F: GAGGGAAATGACTCTCTCAGTAAAA 110 [20]a
R: TGAACAGGATGTGGAAGAAGG
FAM-CAGCCAAATATACGGGCTATCCATCAA-TAMRA
“Candidatus Mycoplasma haemominutum” (16S rRNA gene) F: TGATCTATTGTKAAAGGCACTTGCT 135 [18]
R: TTAGCCTCYGGTGTTCCTCAA
FAM-TTCAATGTGTAGCGGTGGAATGCGT-BHQ1
“Candidatus Mycoplasma turicensis” (16S rRNA gene) F: AGAGGCGAAGGCGAAAACT 138 [18]
R: ACGTAAGCTACAACGCCGAAA
FAM-CGTAAACGATGGGTATTAGATGTCGGGAT-BHQ1
Ehrlichia/Anaplasma spp. (16S rRNA gene) F: GGTACCYACAGAAGAAGTCC 345 [21]
R: TAGCACTCATCGTTTACAGC
Hepatozoon. spp. (18S rRNA gene) F: AAACGGCTACCACATNTAAGGA 522
R: AATACAAATGCCCCCAACTNT
Leishmania spp. (screening assay) (kinetoplast DNA, kDNA) F: CGGGTAGGGGCGTTCTG 115 [19]
R: ATTTTACACCAACCCCCAGTT
FAM-TGGGTGCAGAAATCCCGTTCA-BHQ1
Leishmania spp. (confirmatory assay) (kDNA) F: CCTATTTTACACCAACCCCCAGT 120 [22, 23]
R: GGGTAGGGGCGTTCTGCGAAA
Mycoplasma haemofelis (16S rRNA gene) F: GTGCTACAATGGCGAACACA 80 [18]
R: TCCTATCCGAACTGAGACGAA
FAM-TGTGTTGCAAACCAGCGATGGT-BHQ1
Abbreviations: F forward primer sequence, R reverse primer sequence, FAM 6-carboxyfluorescein on the Taqman probe, BHQ1 black hole quencher 1 on the Taqman
probe, TAMRA Carboxytetramethylrhodamine on the Taqman probe
aThe reverse and probe sequences in the original paper are incorrectly labelled; the correct sequences are cited in this table
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during the validation was purified using the NucleoSpin
PCR and Gel Clean-up kit (Macherey-Nagel, Düren,
Germany) according to the manufacturer's instructions,
quantified with a Qubit™ fluorometer (Thermo Fisher
Scientific, Paisley, UK) and submitted for DNA sequen-
cing at DNA Sequencing and Services (College of Life
Sciences, University of Dundee, Scotland), in both direc-
tions using the same primers as those used for the PCR.
DNA sequencing
Fourteen of the 66 Hepatozoon spp. positive samples
(due to financial constraints) from cats living in all 6 dis-
tricts of Cyprus, and the Ehrlichia/Anaplasma spp. posi-
tive sample were purified, quantified and submitted for
DNA sequencing as described above. All amplicons from
the confirmatory Leishmania spp. qPCR were also
sequenced using the BigDye Terminator v3.1 Cycle Se-
quencing Kit and an ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems, Foster city, USA), at the Center for
Genomic Technologies, Hebrew University of Jerusalem,
Israel. Forward and reverse DNA sequences were assem-
bled, constructed into consensus sequences and aligned
for identification of infecting species according to the
closest NCBI BLAST (www.ncbi.nlm.nih.gov/BLAST)
[25] match against previously deposited GenBank se-
quences. Hepatozoon spp. (KY215805-KY215818) and
Ehrlichia/Anaplasma spp. (KY212527) sequences de-
rived from this study were deposited in the GenBank
database. The sequences from the confirmatory
Leishmania spp. qPCR were not deposited in Gen-
Bank since these species have already been described
in dogs from Cyprus [6].
FeLV and FIV serology
The PetCheck FeLV Antigen Test and PetCheck FIV Anti-
body Test (IDEXX Laboratories, Westbrook, Maine, USA)
were used for the detection of FeLV antigens and anti-
bodies against FIV in the 164 available cat sera samples,
respectively, following the manufacturer’s instructions.
Leishmania infantum serology
Available cat sera from 160 cases were shipped to the
Departament de Medicina i Cirurgia Animal, Facultat de
Veterinaria, Universitat Autonoma de Barcelona, Spain
for L. infantum enzyme-linked immunosorbent assay
(ELISA) testing using a previously described protocol
[26]. A cut-off was established at 32 ELISA units for IgG
(mean ± 3 standard deviations). Each sample was quanti-
fied as ELISA units (EU) relative to a positive control
calibrator cat serum sample, arbitrarily set at 100 EU,
which was included on each plate. A negative control
cat serum, from a cat known not to be Leishmania-in-
fected, was also included on each plate.
Statistical analysis
Only samples that were positive for both qPCR internal
controls using the stipulated Ct cut-offs were included
in the statistical analysis carried out using SPSS for
Windows (version 22.0; SPSS Inc., Chicago IL, USA).
For statistical analysis, four groups of infectious agents
were formed comprising “Any haemoplasma” (positivity
in at least one of the following qPCRs; Mhf, CMhm and
CMt), “L. infantum infection” (positive DNA sequencing
for L. infantum following confirmatory qPCR and/or
positive L. infantum ELISA), “Retroviral serology” (posi-
tive for FeLV and/or FIV serology) and “FVBP” [positive
for at least one of the PCRs for B. henselae, Ehrlichia/
Anaplasma spp. and/or Hepatozoon spp., and/or L.
infantum infection (i.e. positive DNA sequencing for L.
infantum following confirmatory qPCR and/or positive
L. infantum ELISA)].
The Kolmogorov-Smirnov test was used to assess for
normality of distribution of the continuous variable age.
Mann-Whitney U-tests were then used to evaluate for
differences between non-normally distributed variable of
age across infectious agent group(s). Initial analyses
using Chi-square test was performed to evaluate any as-
sociations between the 19 categorical variables across in-
dividual infectious agent group(s). Multivariable logistic
regression was used to test for possible risk factors asso-
ciated with infection. Independent variables that yielded
P-values of < 0.2 in a univariable analysis were then
tested in a multivariable logistic regression analysis.
Backward selection was used primarily, and once a final
model was constructed all the previously excluded vari-
ables were then individually retested and, if then signifi-
cant, were included within the final model. Within the
final multivariable models a P-value ≤ 0.05 was consid-
ered statistically significant for inclusion, and the
P-values with odds ratio (OR) and 95% confidence inter-
val (CI) are reported.
Results
Of the 176 DNA samples analysed, two were excluded
due to failure of one or more of the internal amplifica-
tion control qPCRs, hence 174 samples were used in the
study and subsequent statistical analyses. The age of
these 174 cats ranged from 0.4 to 22.0 years (median
5.6 years, interquartile range 8 years) and only 15 (8.6%)
were pedigree including six Ragdolls, six Persians, two
Siamese and one Russian Blue. Tables 2 and 3 show de-
scriptive statistics as well as data on the prevalence of
infectious agents among the population studied.th=tlb=
Specificity testing for the novel PCR assay for Hepatozoon
spp. against B. canis, Babesia rossi, E. canis, A. phagocyto-
philum, L. infantum, B. clarridgeiae, Mhf, CMhm, CMt, M.
haemocanis, “Ca. M. haematoparvum”, N. caninum and T.
gondii DNA found no evidence of cross-reactivity.
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Table 2 Comparison of prevalence of infectious agents detected by PCR in cats from Cyprus per categorical variable
Variable/category No. of
cats (%)
No. of PCR positive cats (%)
Mhf CMhm CMt Any hp Hepatozoon spp. B. henselae L. infantum
Gender 174
Male 96 (55.2) 7 (7.3) 21 (21.9) 6 (6.3) 25 (26.0) 34 (35.4) 10 (10.4) 2 (2.1)
Female 78 (44.8) 6 (7.7) 15 (19.2) 6 (7.7) 21 (26.9) 32 (41.0) 9 (11.5) 2 (2.6)
Breed 174
Non-Pedigree 159 (91.4) 13 (8.2) 35 (22.0) 12 (7.6) 45 (28.3) 65 (40.9) 19 (12.0) 4 (3.8)
Pedigree 15 (8.6) 0 (0) 1 (6.7) 0 (0) 1 (6.7) 1 (6.7) 0 (0) 0 (0)
Housing 174
Access to outdoors 134 (77.0) 13 (9.7) 35 (26.1) 10 (7.5) 44 (32.8) 55 (41.1) 17 (12.7) 4 (3.0)
Indoors only 40 (23.0) 0 (0) 1 (2.5) 2 (5.0) 2 (5.0) 11 (27.5) 2 (5.0) 0 (0)
Lifestyle 174
Shelter-feral 36 (20.7) 5 (13.9) 24 (66.6) 6 (16.7) 14 (38.9) 20 (55.6) 6 (16.7) 1 (2.8)
Owned 138 (79.3) 8 (5.8) 12 (8.7) 6 (4.3) 32 (23.2) 46 (33.3) 13 (9.4) 3 (2.2)
District 174
Paphos 59 (33.9) 4 (6.8) 14 (23.7) 4 (6.8) 16 (27.1) 23 (39.0) 10 (17.0) 4 (6.8)
Nicosia 51 (29.4) 3 (5.9) 7 (13.7) 2 (3.9) 10 (19.6) 21 (41.2) 4 (7.8) 0 (0)
Larnaca 28 (16.1) 2 (7.1) 5 (17.9) 1 (3.6) 6 (21.4) 8 (28.6) 2 (7.1) 0 (0)
Limassol 22 (12.6) 2 (9.1) 8 (36.4) 3 (13.6) 9 (40.9) 7 (31.8) 3 (13.6) 0 (0)
Famagousta 7 (4.0) 0 (0) 0 (0) 0 (0) 0 (0) 4 (57.1) 0 (0) 0 (0)
Kyrenia 7 (4.0) 2 (28.6) 2 (28.6) 2 (28.6) 5 (71.4) 3 (42.9) 0 (0) 0 (0)
Habitat 174
Rural 65 (37.4) 7 (10.8) 17 (26.2) 6 (9.2) 21 (32.3) 33 (50.8) 8 (12.3) 2 (3.1)
Urban 109 (62.6) 6 (5.5) 19 (17.4) 6 (5.5) 25 (22.9) 33 (30.3) 11 (10.1) 2 (1.8)
Travel history 174
Never travelled abroad 159 (91.4) 13 (8.2) 32 (20.1) 11 (6.9) 42 (26.4) 65 (40.9) 17 (10.7) 4 (2.5)
Travelled abroad 15 (8.6) 0 (0) 4 (26.7) 1 (6.7) 4 (26.7) 1 (6.7) 2 (13.3) 0 (0)
Health status 174
Non-healthy 131 (75.3) 12 (9.2) 33 (25.2) 9 (6.9) 41 (31.3) 58 (44.3) 14 (10.7) 4 (3.1)
Healthy 43 (24.7) 1 (2.3) 3 (6.9) 3 (7.0) 5 (11.6) 8 (18.6) 5 (11.6) 0 (0)
Vaccination status 165
Never vaccinated 47 (28.5) 8 (17.0) 9 (19.2) 7 (14.9) 14 (29.8) 25 (53.2) 4 (8.5) 1 (2.1)
Vaccinated 118 (71.5) 5 (4.2) 23 (19.5) 5 (4.2) 28 (23.7) 36 (30.5) 15 (12.7) 3 (2.5)
Ectoparasitic prevention status 165
Never used 62 (37.6) 8 (12.9) 15 (24.2) 7 (11.3) 21 (33.9) 31 (50.0) 9 (14.5) 2 (3.2)
Used 103 (62.4) 5 (4.9) 17 (16.5) 5 (4.9) 21 (20.4) 30 (29.1) 10 (9.7) 2 (1.9)
Anaemia 132
Anaemic 29 (22.0) 3 (10.4) 9 (31.0) 3 (10.3) 9 (31.0) 13 (44.8) 3 (10.4) 1 (3.5)
Non-anaemic 103 (78.0) 6 (5.8) 18 (17.5) 5 (4.9) 23 (22.3) 33 (32.0) 16 (15.5) 3 (2.9)
FeLV 164
Positive 10 (6.1) 1 (10.0) 3 (30.0) 2 (20.0) 3 (30.0) 5 (50.0) 0 (0) 1 (10.0)
Negative 154 (93.9) 10 (6.5) 30 (19.5) 9 (5.8) 39 (25.3) 59 (38.3) 18 (11.7) 3 (2.0)
FIV 164
Positive 31 (18.9) 4 (12.9) 17 (54.8) 7 (22.6) 19 (61.3) 17 (54.8) 5 (16.1) 1 (3.2)
Negative 133 (81.1) 7 (5.3) 16 (12.0) 4 (3.0) 23 (17.3) 47 (35.3) 13 (9.8) 3 (2.3)
Total 174 13 (7.5) 36 (20.7) 12 (6.9) 46 (26.4) 66 (37.9) 19 (10.9) 4 (2.3)
Abbreviations: Mhf Mycoplasma haemofelis, CMhm “Candidatus Mycoplasma haemominutum”, CMt “Candidatus Mycoplasma turicensis”, Any hp
positivity in at least one of the following haemoplasma PCR; Mhf, CMhm and CMt, B. henselae Bartonella henselae, L. infantum Leishmania infantum
confirmed by DNA sequencing following confirmatory quantitative PCR, FeLV feline leukaemia virus, FIV feline immunodeficiency virus
Note: Only one cat was positive for Ehrlichia/Anaplasma spp. PCR and information regarding this case is reported in the results section of the
main text
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Analytical sensitivity of the assay was assessed as follows.
An amplicon from a known H. canis positive sample was
quantified using a Qubit™ fluorometer (Invitrogen™) and
gave 13.2 ng/μl. A 10-fold serial dilution was made
from 10-8 to 10-12, and each dilution was amplified in
triplicate using the same conditions as described in
the methods. Diluting the amplicon to 10-10 gave a 3
out of 3 success rate for detection and 10-11 a 2 out
Table 3 Comparison of prevalence of infectious agents in cats detected by serology from Cyprus per categorical variable
Variable/category No. of
cats (%)
No. of serology positive cats (%) No. of
cats (%)
No. of serology
positive cats for
L. infantum (%)
FeLV FIV
Gender 164 160
Male 88 (53.7) 7 (8.0) 18 (20.5) 86 (53.8) 3 (3.5)
Female 76 (46.3) 3 (4.0) 13 (17.1) 74 (46.2) 4 (5.4)
Breed 164 160
Non-Pedigree 149 (90.9) 10 (6.7) 31 (20.8) 147 (91.9) 7 (4.8)
Pedigree 15 (9.2) 0 (0) 0 (0) 13 (8.1) 0 (0)
Housing 164 160
Access to outdoors 125 (76.2) 5 (4.0) 29 (23.2) 124 (77.5) 7 (5.7)
Indoors only 39 (23.8) 5 (12.8) 2 (5.1) 36 (22.5) 0 (0)
Lifestyle 164 160
Shelter-feral 33 (20.1) 1 (3.0) 14 (42.4) 33 (20.6) 3 (9.1)
Owned 131 (79.9) 9 (6.9) 17 (13.0) 127 (79.4) 4 (3.2)
District 164 160
Paphos 57 (34.8) 1 (1.8) 13 (22.8) 56 (35.0) 1 (1.8)
Nicosia 48 (29.3) 1 (2.1) 8 (16.7) 44 (27.5) 3 (6.8)
Larnaca 25 (15.2) 3 (12.0) 3 (12.0) 26 (16.3) 0 (0)
Limassol 21 (12.8) 2 (9.5) 5 (23.8) 21 (13.1) 3 (14.3)
Famagousta 7 (4.3) 1 (14.3) 0 (0) 7 (4.4) 0 (0)
Kyrenia 6 (3.7) 2 (33.3) 2 (33.3) 6 (3.7) 0 (0)
Habitat 164 160
Rural 60 (36.6) 3 (5.0) 13 (21.7) 62 (38.8) 3 (4.8)
Urban 104 (63.4) 7 (6.7) 18 (17.3) 98 (61.2) 4 (4.1)
Travel history 164 160
Never travelled abroad 149 (90.9) 10 (6.7) 27 (18.1) 145 (90.6) 7 (4.8)
Travelled abroad 15 (9.2) 0 (0) 4 (26.7) 15 (9.4) 0 (0)
Health status 164 160
Non-healthy 123 (75.0) 10 (8.1) 29 (23.6) 117 (73.1) 6 (5.1)
Healthy 41 (25.0) 0 (0) 2 (4.9) 43 (26.9) 1 (2.3)
Vaccination status 156 151
Never vaccinated 43 (27.6) 4 (9.3) 8 (18.6) 43 (28.5) 4 (9.3)
Vaccinated 113 (72.4) 6 (5.3) 20 (17.7) 108 (71.5) 2 (1.9)
Ectoparasitic prevention status 156 151
Never used 57 (36.5) 2 (3.5) 15 (26.3) 58 (38.4) 4 (6.9)
Used 99 (63.5) 8 (8.1) 13 (13.1) 93 (61.6) 2 (2.2)
Anaemia 128 120
Anaemic 28 (21.9) 4 (14.3) 10 (35.7) 28 (23.3) 2 (7.1)
Non-anaemic 100 (78.1) 3 (3.0) 15 (15.0) 92 (76.7) 1 (1.1)
Total 164 10 (6.1) 31 (18.9) 160 7 (4.4)
Abbreviations: FeLV feline leukaemia virus, FIV feline immunodeficiency virus
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of 3 success rate; none of the triplicates at the 10-12
dilution gave a positive result. Using the amplicon
length of 504 bp and concentration of 13.2 ng/μl, the
theoretical limit of detection was calculated as being
between 1.2 and 12 copies per PCR. Sequencing of
the amplicons derived using the H. canis and H. felis
known positive control DNA samples were found to
match the expected H. canis or H. felis sequences.
Ninety-six (55.2%) of the 174 cats were PCR-positive
for at least one infectious agent, 79 (45.4%) were positive
to at least one FVBP while 17 (9.8%) were positive for
two FVBP (Table 4). Forty-six cats (26.4%) were positive
for haemoplasmas, including 13 (7.5%) for Mhf, 36
(20.7%) for CMhm and 12 (6.9%) for CMt (Table 2).
Sixty-six cats (37.9%) were positive for Hepatozoon spp.,
while nineteen (10.9%) were positive for B. henselae.
One cat (0.6%) was PCR positive for Ehrlichia/Ana-
plasma spp. This was a 19-year-old, neutered female,
domestic shorthair cat from the Paphos area (rural) that
was presented for monitoring of chronic kidney disease.
The cat had lived in Greece for 12 years, was fully vacci-
nated, with access to the outdoors and was treated with
a preventative ectoparasiticide. No abnormalities or A.
platys morulae were found on haematological analysis
and blood smear examination, and the cat was PCR
positive only for Hepatozoon spp. and negative for the
other infectious agents screened for in the study. Using
the Leishmania spp. confirmatory qPCR assay, DNA was
detected in 4 (2.3%) of the 174 cats and L. infantum ser-
ology was positive in 7 of the 160 cats tested (4.4%).
Only one cat was positive by both Leishmania spp. con-
firmatory qPCR assay and serology, and additionally had
cutaneous lesions caused by Leishmania infection
reported by the veterinarian. Of the 164 cats that under-
went retroviral serology, 10 (6.1%) were FeLV, and 31
(18.9%) were FIV, positive (Table 3).
Out of the 66 samples that were positive for Hepato-
zoon spp., 14 amplicons (accession numbers KY215805
to KY215818) were sequenced and yielded 96–100%
similarity to an existing partial 18S rRNA gene for H.
felis (KC138534) over 504 bp. The cat that was positive
on the generic Ehrlichia/Anaplasma spp. PCR yielded
an amplicon (KY212527) that had 99% similarity to a
partial 16S rRNA gene sequence of A. platys (KY114935)
over 225 bp. The four amplicons of the positive con-
firmatory Leishmania spp. qPCR (Additional file 1)
had 93–98% similarity to kinetoplast DNA from an
existing GenBank sequence for L. infantum (Z35292)
over 122 bp.
Univariable analysis showed that many variables had a
trend toward significance (P < 0.2) for association with
the presence of individual, or groups of infectious
agent(s) (Table 5, Table 6, Additional file 2: Table S1,
Additional file 3: Table S2), and these were entered into
the multivariable logistic regression analysis, together
with variables having significant associations (P ≤ 0.05).
Thirteen sets of multivariable logistic regression, one
for each infectious agent or group of infectious agents,
were constructed using the independent variables that
showed at least a trend towards significance (P < 0.2) in
the univariable analysis. Eight multivariable models
yielded significant associations (P ≤ 0.05) (Table 7). No
multivariable models yielded significant associations for
Mhf, B. henselae, L. infantum PCR, L. infantum serology
or FeLV.
Discussion
This is the first large-scale study to provide an overview
of infectious agents in cats from Cyprus. Feline haemo-
plasmas, B. henselae, Hepatozoon spp. (including H.
felis), L. infantum and A. platys were detected by PCR
(with or without sequencing), while serology revealed in-
fections with FeLV, FIV and L. infantum in the feline
population of this island. Additionally, significant associ-
ations were identified between infectious agents and in-
dependent, risk factor variables using multivariable
logistic regression, providing a better understanding of
the epidemiology and possible risk factors for these
infectious agents.
Over the last few decades, feline hepatozoonosis
has been increasingly reported worldwide with prev-
alences being frequently low, but ranging up to 36%
depending on geographical location and lifestyle of
cats [11, 13, 15, 27–30]. The exact vectors and
routes of transmission of feline hepatozoonoses are
not known [27], but vectorial transmission likely
plays a key role as for other species of Hepatozoon
Table 4 Prevalence of single infections and co-infections with
feline vector-borne pathogens including Bartonella henselae,
Ehrlichia/Anaplasma spp. and Hepatozoon spp. determined by
PCR, as well as Leishmania infantum infection, among 174 cats
from Cyprus
Infectious agent(s) Positive cats
No. %
Single infections 62 35.7
B. henselae 11 6.3
Hepatozoon spp. 49 28.2
L. infantum infectiona 2 1.2
Co-infections 17 9.8
Ehrlichia/Anaplasma spp. and Hepatozoon spp. 1 0.6
B. henselae and Hepatozoon spp. 8 4.6
L. infantum infectiona positive and Hepatozoon spp. 8 4.6
Total 79 45.5
aPositive L. infantum infection status defined as cats that had positive DNA
sequencing for L. infantum following confirmatory qPCR and/or positive L.
infantum ELISA
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in different vertebrate species such as dogs [31]. The
results of the present study demonstrate the utility
of the novel Hepatozoon spp. PCR assay for the de-
tection of H. canis and H. felis and the absence of
cross-reaction with a range of other pathogens. In
this study, we found a prevalence of 37.9% for
Table 7 Variables for the positivity of infectious agents or groups of
infectious agents in cats in Cyprus: multivariable logistic regression
models
Odds ratio (95% CI) P-value
1. CMhm PCR positive
Retroviral serology status
Positive 5.8 (2.4–14.0) 0.001
Negative Ref.
Age 1.1 (1.1–1.2) 0.017
Lifestyle
Shelter-feral 2.8 (1.1–7.4) 0.043
Owned Ref.
2. CMt PCR positive
L. infantum infection status
Positive 7.3 (1.4–37.5) 0.018
Negative Ref.
Retroviral serology status
Positive 5.0 (1.3–219.7) 0.021
Negative Ref.
3. Any haemoplasma PCR positive
Retroviral serology status
Positive 4.6 (2.1–10.4) 0.001
Negative Ref.
Housing
Access to outdoors 8.7 (1.9–39.1) 0.005
Indoors only Ref.
4. L. infantum infection positive
Hepatozoon spp. PCR status
Positive 13.5 (1.6-111.1) 0.016
Negative Ref.
CMt PCR status
Positive 5.6 (1.1–29.1) 0.041
Negative Ref.
5. FIV serology positive
Any haemoplasma PCR status
Positive 6.6 (2.7–15.9) 0.001
Negative Ref.
Lifestyle
Shelter-feral 4.0 (1.6–10.2) 0.004
Owned Ref.
Table 7 Variables for the positivity of infectious agents or groups of
infectious agents in cats in Cyprus: multivariable logistic regression
models (Continued)
6. Retroviral serology positive
Any haemoplasma PCR status
Positive 5.3 (2.1–13.4) 0.001
Negative Ref.
Anaemia
Anaemic 3.6 (1.4–9.5) 0.008
Non-anaemic Ref.
7. Hepatozoon spp. PCR positive
Health status
Non-healthy 3.2 (1.3–7.8) 0.010
Healthy Ref.
L. infantum infection status
Positive 12.0 (1.4–106.0) 0.025
Negative Ref.
Vaccination status
Never vaccinated 2.2 (1.1–4.7) 0.048
Vaccinated Ref.
8. FVBP positive
Habitat status
Rural 2.6 (1.3–5.2) 0.006
Urban Ref.
CMt PCR status
Positive 22.5 (2.3–221.2) 0.008
Negative Ref.
Health status
Non-healthy 2.4 (1.1–5.4) 0.042
Healthy Ref.
Travel history
Never travelled abroad 4.3 (1.1–18.0) 0.045
Travelled abroad Ref.
Abbreviations: CI confidence interval, Ref. reference category, CMhm “Candidatus
Mycoplasma haemominutum”, CMt “Candidatus Mycoplasma turicensis”, L.
infantum infection positive DNA sequencing for Leishmania infantum following
confirmatory qPCR and/or positive L. infantum ELISA, Any haemoplasma
positivity in at least one of the following haemoplasma PCRs; Mhf, CMhm and
CMt, FIV feline immunodeficiency virus, Retroviral serology positive for FeLV
and/or FIV serology, FVBP positive for at least one of the PCRs for B. henselae,
Ehrlichia/Anaplasma spp. and/or Hepatozoon spp., and/or L. infantum infection
(i.e. positive DNA sequencing for L. infantum following confirmatory qPCR and/
or positive L. infantum ELISA)
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Hepatozoon spp. infection in cats, with an even
higher prevalence of 55.5% in shelter-feral cats.
Amplicon sequencing revealed the presence of H.
felis only, but we cannot rule out the possibility of some
cats being infected with H. canis since not all positive
PCR products were sequenced due to financial con-
straints, and H. canis has been previously reported to in-
fect cats [27] and has been described in Cyprus [17].
Univariable statistical analysis revealed ten variables asso-
ciated with Hepatozoon spp. infection from which three
(non-healthy, L. infantum infection positive status and
never vaccinated) remained statistically significant in the
multivariable logistic regression model. To our knowledge,
this is the first time that associations have been found
using multivariable logistic regression for feline hepato-
zoonosis. The association (OR = 3.2, 95% CI: 1.3–7.8,
P = 0.010) between Hepatozoon spp. infection and
health status, with non-healthy cats being three times
more likely to be Hepatozoon spp. infected compared
to healthy cats, is interesting since feline hepatozoo-
nosis has been described as being predominantly a
sub-clinical infection [27]. This association does not
necessarily mean that the cause of the cats’ ill-health
was hepatozoonosis, especially since the cats were
often co-infected with other pathogens; therefore fur-
ther studies are needed to identify the clinical impli-
cations of hepatozoonosis in cats. Cats with a positive
L. infantum infection status were 12 times more likely
to be infected with Hepatozoon spp. (OR = 12.0, 95%
CI: 1.4–106.0, P = 0.025) compared to cats with L.
infantum infection negative status. This co-infection
is commonly reported in dogs with H. canis [32], and
it is the first time that such association has been re-
ported in cats. Co-infection with these two proto-
zoans might lead to higher level of circulating
parasites due to impaired response of the host im-
mune system [33]. The reason for the significant as-
sociation between Hepatozoon spp. infection and
negative vaccination status is unknown, but could be
due to an association with an overall lack of pre-
ventative health care.
Similar to dogs, L. infantum infection in cats is most
likely transmitted by phlebotomine sand flies and is cur-
rently an emerging zoonotic infectious disease [34]. The
current study’s findings of a L. infantum PCR-based
prevalence of 2.3% (confirmed by DNA sequencing fol-
lowing confirmatory quantitative PCR), L. infantum
seroprevalence of 4.4% and a combined infection (i.e.
positive DNA sequencing for L. infantum following con-
firmatory qPCR and/or positive L. infantum ELISA)
prevalence of 5.8%, are similar to those reported in other
Mediterranean countries [15, 26, 35, 36], although lower
than the 14.9% seroprevalence in dogs from Cyprus [6].
Only one sick cat, which had cutaneous lesions caused
by Leishmania infection, was positive by both serology
and PCR with confirmed L. infantum on sequencing.
Sequencing showed L. infantum in another three cats,
and this agreed with a previous study in Cyprus on dogs,
where also only L. infantum was found [6]. The variables
of male gender, adult age, rural habitat [37], outdoor life-
style [34] and retroviral positivity [26], which are all pre-
viously reported risk factors for leishmaniosis in cats,
were not found to be significant in this study. However,
significant associations between L. infantum infection
status and infection with Hepatozoon spp. (OR = 13.5,
95% CI: 1.6–111.1, P = 0.016) and CMt (OR = 5.6, 95%
CI: 1.1–29.1, P = 0.041) were found by multivariable
logistic regression. Possible causes of these associations
may reflect pathogen-facilitation or phenotypic traits
(e.g. aggressiveness) that were not recorded during the
study [38].
The prevalence of haemoplasma infection in cats in
this study was similar to those reported in other
European countries [10, 39–45], with CMhm infection
being most common, followed by Mhf and CMt. Multi-
variable logistic regression analyses (Table 7) showed
significant associations between positive retroviral status
and each of CMhm (OR= 5.8, 95% CI: 2.4–14.0, P =0.001),
CMt (OR = 5.0, 95% CI: 1.3–219.7, P = 0.021) and overall
haemoplasma infection (OR = 4.6, 95% CI: 2.1–10.4,
P = 0.001). This supports the previous reports that
retroviral infections, especially FIV, are risk factors
for haemoplasma infection [43, 46]. Consistent with
previous studies [40, 45–47], our study also identi-
fied additional risk factors including age (OR = 1.1,
95% CI: 1.1–1.2, P = 0.017) and being a shelter-feral
cat (OR = 2.8, 95% CI: 1.1–7.4, P = 0.043) for CMhm
infection, and access to outdoors (OR = 8.7, 95% CI:
1.9–39.1, P =0.005) for infection with any haemo-
plasma species. Interestingly, this is the first time L.
infantum infection in cats (OR = 7.3, 95% CI: 1.4–
37.5, P = 0.018) has been associated with CMt infec-
tion, with Leishmania infected cats being seven
times more likely to be CMt-positive.
Molecular investigation detected B. henselae in 10.9%
of the cats in this study, which is amongst the highest
prevalence of infection reported in Europe [9–11, 15, 16].
A recent study from southern Italy [9] reported a 21.4%
PCR prevalence of B. henselae in outdoor cats that had at
least one ectoparasite (tick or flea) present on examin-
ation. In the current study both indoor and outdoor cats
were included, but ectoparasite presence was not assessed.
Despite being a zoonotic infection, this is the first time
that B. henselae has been detected in Cyprus, although
10.5% of rats in Cyprus have been shown to be seroposi-
tive for B. henselae [48]. Other Bartonella species could
possibly exist in Cyprus, but were not investigated, thus
further studies are needed.
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In our study, 18.9 and 6.1% of the cats were seropositive
for FIV and FeLV, respectively, findings which are similar
to those reported in previous studies [49–53]. Multivari-
able logistic regression revealed significant associations
between FIV and haemoplasma infection (OR = 6.6, 95%
CI: 2.7–15.9, P = 0.001) and FIV infection and shelter-feral
cats (OR = 4.0, 95% CI: 1.6–10.2, P = 0.004). In addition,
overall retroviral infection was associated with haemo-
plasma infection (OR = 5.3, 95% CI: 2.1–13.4, P = 0.001)
and anaemia (OR = 3.6, 95% CI: 1.4–9.5, P = 0.008). To
our knowledge, this is the first time multivariable logistic
regression has documented an association of seropositivity
with shelter-feral cats, and retroviral seropositivity with
anaemia.
Anaplasma platys is considered a VBP, that is wide-
spread in dogs from the Mediterranean basin and has
also been reported in dogs, sheep and goats from
Cyprus [17, 54, 55]. There are sporadic reports of this
canine pathogen in cats from North America and
Brazil [7, 56, 57], and recently A. platys-like strains
were identified in cats from Sardinia, Italy [58]. In
this study, we report a case of presumptive A. platys
infection in a cat from Cyprus based on partial se-
quencing of 16S rRNA gene. However, further investi-
gation with additional phylogeny and amplification of
multiple and longer genes are needed, in order to de-
finitively prove the identity of this pathogen. In this
case, as well as in the previous feline case reports
[56, 57], the pathogenic role of A. platys in cats is
not clear.
The overall prevalence of FVBP in this study is higher
than those reported in studies performed in other south-
ern European countries [9, 11, 13]. Logistic regression
analyses showed significant associations between FVBP
infection and rural habitat, as well as never having trav-
elled abroad, indicating that such infections are largely
driven by eco-environmental conditions favouring the
infestation of arthropod vectors that transmit pathogens
to cats. To date, no studies have investigated the pres-
ence of arthropod vectors in cats from Cyprus, however
ectoparasites described in Cyprus include the ticks
Rhipicephalus sanguineus, Rhipicephalus pusillus, Ixodes
ventalloi [2], the cat flea Ctenocephalides felis [5] and
phlebotomine sand flies such as Phlebotomus tobbi,
Phlebotomus galilaeus, and Phlebotomus papatasi [6].
Conclusions
The results from this study demonstrate that FVBP,
feline haemoplasmas and retroviral infections are
present with considerable prevalence in the feline
population of Cyprus. These findings should alert
owners, the veterinary community and public health
authorities to the possible risk of transmission of
zoonotic FVBP including B. henselae and L. infan-
tum. Priority should be given to establishing a sur-
veillance system for arthropod vectors and FVBP in
cats in order to monitor their distribution and pre-
vent further spreading of these pathogens with regu-
lar effective prophylactic measures, such as the use
of ectoparasite prevention in cats.
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